P

Inventor

PETERSON JOHN M

US43 patents
⚠️ This page may combine multiple inventors who share the name “PETERSON JOHN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NEUROGEN CORP

21 patents
US6316617B1Nov 13, 2001

Certain amido-and amino-substituted benzylamine derivatives; a new class of Neuropeptide Y1 specific ligands

NEUROGEN CORP17 citations92
US6133265AOct 17, 2000

Certain amido- and amino- substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands

NEUROGEN CORP33 citations92
US6069251AMay 30, 2000

Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4- substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands

NEUROGEN CORP25 citations92
US5962455AOct 5, 1999

Certain substituted benzylamine derivatives a new class of neuropeptide Y1 specific ligands

NEUROGEN CORP44 citations92
US5712392AJan 27, 1998

Certain 4-piperidine- and piperazinoalkyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands

NEUROGEN CORP21 citations92
US5633377AMay 27, 1997

4-piperidino- and piperazinomethyl-2-cyclohexyl imidazole derivatives; dopamine receptor subtype specific ligands

NEUROGEN CORP18 citations92
US7160879B2Jan 9, 2007

Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues

NEUROGEN CORP26 citations90
US7253168B2Aug 7, 2007

Substituted 1-benzyl-4-substituted piperazine analogues

NEUROGEN CORP13 citations82
US5656762AAug 12, 1997

4-piperidino-and piperazinomethyl-2-phenylimidazole derivatives, dopamine receptor subtype specific ligands

NEUROGEN CORP9 citations82
US6797824B2Sep 28, 2004

Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands

NEUROGEN CORP4 citations74
US6358955B1Mar 19, 2002

Substituted imidazoles as subtype specific dopamine receptor ligands and pharmaceutical compositions containing such substituted imidazole

NEUROGEN CORP5 citations74
US5985873ANov 16, 1999

Certain substituted benzylamine derivatives a new class of Neuropeptide-Y1 specific ligands

NEUROGEN CORP9 citations74
US5646281AJul 8, 1997

Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands

NEUROGEN CORP6 citations74
US6916819B2Jul 12, 2005

Benzimidazole and pyridylimidazole derivatives

NEUROGEN CORP5 citations73
US6953801B2Oct 11, 2005

Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues

NEUROGEN CORP11 citations72
US6420365B1Jul 16, 2002

Imidazopyridines and related derivatives as selective modulators of bradykinin B2 receptors

NEUROGEN CORP9 citations72
US6358949B1Mar 19, 2002

Aryl and hetroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptors

NEUROGEN CORP10 citations72
US7728009B1Jun 1, 2010

Thiazole amides, imidazole amides and related analogues

NEUROGEN CORP6 citations61
US7851474B2Dec 14, 2010

Dipiperazinyl ketones and related analogues

NEUROGEN CORP3 citations60
US7241765B2Jul 10, 2007

Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues

NEUROGEN CORP0 citations50
US7081458B2Jul 25, 2006

Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues

NEUROGEN CORP1 citations50

GLYCOMIMETICS INC

8 patents

JUNIPER NETWORKS INC

5 patents

TELEDYNE IND

2 patents

US NAVY

1 patent

CHEMTREE CORP

1 patent

HALL WILLIAM C

1 patent

INTEL CORP

1 patent

ABB RESEARCH LTD

1 patent

DAS RATAN

1 patent

DETOFSKY ABRAM M

1 patent